Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty — Stella

Home/Knee Replacement Surgery/

View on ClinicalTrials.gov

Recruiting

Back to Knee Replacement Surgery trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

University of Michigan, Ann Arbor, Michigan

Henry Ford Health System, Detroit, Michigan

Key details

Phase

Safety & dosing

Sponsor

Chad Brummett

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Enrollment target

~380 participants

Started

March 2024

Primary completion

January 2029

Age range

18 Years – 80 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.